The Benzodiazepine Kindling Effect

Benzodiazepine kindling describes concern that repeated withdrawals may increase seizure-related sensitivity, although evidence does not show that every withdrawal gets worse. Your withdrawal history can guide individualized care, and a difficult past attempt does not mean you have lost the chance to improve.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Is Kindling?

Kindling means a response may become easier to trigger or more intense after repeated episodes. With benzodiazepines, the concern is that repeated withdrawals could increase seizure susceptibility or severity. The evidence does not establish that every withdrawal becomes worse or that all withdrawal symptoms intensify together.[1][2]

The name uses a fire metaphor: kindling makes a fire easier to start. In this context, sensitization means becoming more responsive to a trigger.[4]

Benzodiazepines affect calming activity in the nervous system, and regular use can lead the body to adapt. Withdrawal can occur when the medicine is reduced or stopped. The kindling idea concerns whether repeated withdrawals produce additional sensitivity. The metaphor itself cannot tell us what has happened in an individual person’s brain.[1][3][4]

If you searched for “kindling benzo withdrawal” after a prescription gap left you feeling unwell, that experience deserves attention. Write down when the interruption happened and what followed. This history can help guide assessment without requiring you to diagnose kindling yourself.[1][3]

If you are still without your regular medicine, contact your prescriber or pharmacist promptly rather than waiting, because suddenly stopping regular use can cause serious withdrawal, including seizures.[1][3] AddictionHelp.com’s benzodiazepine overview explains the broader differences between prescribed use, dependence and addiction.[1][3]

Fast Facts About Benzodiazepine Kindling
  • Benzodiazepine kindling describes concern about increased sensitivity after repeated withdrawal episodes, particularly seizure-related effects.[1][2]
  • A mouse study found increased sensitivity to a seizure-provoking challenge without a matching progressive increase in anxiety-like behavior.[2]
  • Physical dependence can develop during prescribed benzodiazepine use and does not by itself mean addiction.[1][3]
  • An individualized, medically supervised taper can lower withdrawal risk, but it cannot guarantee that seizures or kindling will be prevented.[1][3]

What Evidence Supports Benzo Kindling?

There is direct benzodiazepine-related evidence from mice, along with clinical concern in people. These are different kinds of evidence, and neither establishes that each human withdrawal must be worse than the last.[1][2]

In their 1998 mouse study, Ward and Stephens found that repeated withdrawal from diazepam increased sensitivity to a seizure-provoking laboratory challenge. Anxiety-like behavioral measures did not show a parallel progressive increase, and some anxiety-like responses were reduced. Seizure sensitivity and anxiety were separate outcomes.⁠[2]

This finding cannot provide a person’s seizure probability or tell us how often seizures occur during a supervised taper. A laboratory challenge in mice is also different from observing unprovoked clinical withdrawal seizures in people. For example, feeling more anxious during a later withdrawal does not measure your seizure threshold or prove progressive kindling. Report that anxiety because it needs care, without treating its intensity as a seizure-risk test.[1][2]

The American Society of Addiction Medicine (ASAM) addresses kindling in its 2025 joint clinical guideline. It describes concern about increasing seizure severity with repeated withdrawals, particularly among addiction medicine clinicians caring for people with previous withdrawal seizures.[1]

The guideline also notes differences between addiction medicine and neurology practice. Its panel did not reach consensus on seizure-risk management, including preventive medication use. This uncertainty concerns how to manage risk, not whether abrupt benzodiazepine withdrawal can be dangerous.[1]

A useful question for your prescriber is: “How does my previous withdrawal history change the monitoring or level of care I need?” That turns the evidence into a decision about your care without assuming that a mouse finding predicts your outcome.[1][2]

How Benzodiazepine Kindling Relates to Alcohol

Alcohol kindling provides related evidence and helps explain why clinicians take repeated withdrawal seriously. It does not directly establish what will happen during benzodiazepine withdrawal. Becker’s 1998 review describes both clinical associations between repeated alcohol withdrawals and greater withdrawal severity, including seizures, and findings from animal models.[4]

Alcohol and benzodiazepines both affect the balance of calming and excitatory activity in the nervous system. That shared feature is too broad to establish identical withdrawal mechanisms, risks or treatment needs. Evidence about medicines used to treat alcohol withdrawal cannot guarantee seizure prevention during benzodiazepine withdrawal.[1][4]

For example, a seizure-risk estimate from an alcohol-withdrawal study cannot be used as your personal risk estimate when reducing a prescribed benzodiazepine. Tell your clinician about any history of alcohol withdrawal and your current alcohol use, since both can affect care planning. Do not use alcohol to manage benzodiazepine withdrawal symptoms.[1][3][4]

Why Repeated Stopping and Restarting Matters

Repeated stopping and restarting matters because each interruption can trigger withdrawal in a physically dependent person. Discussions of kindling withdrawal add the concern that repeated episodes might increase seizure-related sensitivity. A more difficult experience alone cannot identify that mechanism.[1][3][2]

Several terms describe different experiences. Physical dependence means the body has adapted to the medicine, so reducing or stopping it can cause withdrawal. The U.S. Food and Drug Administration (FDA) warns that dependence can develop within days to weeks of steady use, even when taken as prescribed.[1][3]

Tolerance means a medicine has less effect with continued use. Addiction involves a broader pattern of impaired control and continued use despite harm. Dependence and addiction can coexist, but dependence alone does not establish addiction or kindling.[1][3]

For example, worse insomnia during a later attempt could involve withdrawal, the return of the original sleep problem, or changes in other medicines or substances. Note when the sleep problem changed, what else changed and how it affects daily life. Those details help a clinician assess possible causes instead of assuming that every symptom comes from kindling.[1][3]

The guide to benzodiazepine dependence versus addiction explains why these distinctions matter for treatment.[1][3]

Can Benzodiazepine Withdrawal Be Fatal?

Yes. The FDA warns that abruptly stopping or rapidly reducing benzodiazepines can cause life-threatening withdrawal, including seizures. A gradual, individualized taper under medical supervision lowers withdrawal risk, but no plan can guarantee that seizures or other serious complications will not occur.[1][3]

A previous seizure or other complicated withdrawal is important when choosing a care setting. Some people need hospital care or another medically managed setting, while others can receive outpatient care. For example, a past withdrawal seizure needs to be discussed before another reduction, even if you currently feel well. The assessment should consider your whole history rather than waiting for proof of kindling.[1]

In the U.S., call 911 for a seizure, trouble breathing or another medical emergency. Do not wait to determine whether kindling is involved.[3]

For suicidal crisis or emotional distress in the U.S., call 988 or text 988. These crisis-support contacts serve a different role from emergency medical care for seizures or breathing problems.[5][3]

Does the Kindling Effect Ever Go Away?

There is no established human timetable for benzodiazepine kindling to disappear. The available sources also do not show that a difficult withdrawal proves permanent brain damage. Withdrawal symptoms and everyday functioning can improve with time and appropriate care, although that improvement does not demonstrate that a measured kindling process has reversed.[1][2][4]

Some people have prolonged withdrawal symptoms lasting months or years. Persistent symptoms deserve assessment and ongoing support, including attention to other possible causes. Their duration alone cannot establish kindling or predict an individual’s eventual recovery.[1]

For example, being able to prepare a meal or concentrate on a short conversation can be meaningful progress even while sleep remains difficult. Keep brief notes about symptoms and what you can do, then use follow-up appointments to discuss both improvements and continuing limitations. AddictionHelp.com’s benzodiazepine withdrawal guide covers prolonged symptoms, care needs and difficult previous tapers.[1]

What to Do After a Difficult Withdrawal

Arrange a medication and withdrawal-history review with your prescriber before making another change. A difficult previous attempt gives the care team useful information. It does not establish that the attempt was too fast, that you caused harm, or that future care cannot help. Do not stop, restart or change your dose on your own.[1][3]

A useful assessment should connect your history with decisions about treatment, monitoring and support. Bring information about these areas:[1][3]

  • Current medicines and substances. Bring a medication list or containers, including nonprescription products. Explain what you actually take, any interruptions in access, and alcohol or other substance use. This helps the clinician identify interactions and withdrawal risks.[1][3]

  • Previous withdrawal experiences. Describe what changed, what symptoms followed and whether you had a seizure or another serious complication. Include emergency visits or hospital care if they occurred.[1]

  • The medicine’s current benefits and risks. Review why it was prescribed and whether it still helps. Depending on your situation, the shared decision may involve continuing treatment, reducing the dose or working toward discontinuation. Not everyone taking a prescribed benzodiazepine needs to stop.[1]

  • Health and daily functioning. Discuss anxiety, sleep, other medical or mental health conditions, and changes in work, self-care or relationships. These needs deserve treatment alongside any withdrawal plan.[1]

  • Support and access to care. Explain who can help at home, how you will attend follow-up appointments and whether prescription access is uncertain. These practical details affect how a plan can be carried out.[1]

For example, if a previous attempt ended because sleeplessness made it impossible to work, describe both the sleep changes and their effect on functioning. Ask: “What will we do if this happens again?” Also agree on whom to contact between visits and what circumstances would require more intensive care. A usable plan addresses foreseeable problems rather than expecting you to endure them without help.[1]

If you no longer have a prescriber, contact a primary-care service for medical assessment and explain your regular benzodiazepine use and any previous serious withdrawal. If a prescription gap is approaching or has already begun, contact your prescriber and pharmacist promptly. A therapy service alone cannot replace medical withdrawal assessment or prescribing care.[1][3]

What Support Can Help During and After a Taper?

Medical follow-up, treatment for ongoing anxiety or sleep problems, and practical support can help make a taper more manageable. Care should respond to symptoms and daily functioning, with follow-up continuing after discontinuation when needed. A previous unsuccessful attempt does not mean there was only one opportunity to get care right.[1]

Cognitive behavioral therapy (CBT) can address anxiety, and CBT for insomnia (CBT-I) targets sleep problems. Behavioral treatment alongside tapering may improve the likelihood of discontinuing a benzodiazepine, although the guideline rates the relevant evidence as low certainty. These findings do not establish a kindling-specific cure or reversal.[1]

For example, if fear of another sleepless night is making a planned reduction feel overwhelming, a therapist can help address sleep-related worry while the prescriber evaluates withdrawal and other causes of poor sleep. A trusted person can help with meals, appointments or communicating changes. Peer support may also help you feel less isolated, while medication decisions remain with your medical care team.[1]

Before a reduction, agree on how you will report problems, when follow-up will occur and how the clinician will review whether the plan remains appropriate. The goal is an individualized course of care that can respond to your needs. AddictionHelp.com’s guide to planning a supervised benzodiazepine taper explains the gradual-reduction principle and the role of ongoing support.[1][3]

Frequently Asked Questions

What Is the Kindling Effect with Benzodiazepines?

The benzodiazepine kindling effect is the concern that repeated withdrawal episodes may increase sensitivity to withdrawal, especially seizure susceptibility or severity. Sensitization means becoming more responsive to a trigger. Evidence does not establish that every withdrawal becomes worse or that every symptom increases together.[1][2]

For example, feeling more anxious after a medication interruption does not prove kindling. Describe the interruption, symptoms and any previous serious withdrawal to your prescriber so the history can inform care. Physical dependence can develop during prescribed use and does not by itself mean addiction.[1][3]

Is Benzodiazepine Kindling Actually Proven?

There is direct experimental evidence in mice, but no basis in these sources for declaring that every human withdrawal gets worse. Ward and Stephens’ 1998 study found increased sensitivity to a seizure-provoking challenge after repeated diazepam withdrawal. Anxiety-like behavioral measures did not progressively increase in parallel. This cannot establish a person’s seizure probability or the seizure rate during supervised tapering.[2]

The American Society of Addiction Medicine’s 2025 joint guideline recognizes kindling as a clinical concern. Its panel did not reach consensus on seizure-risk management, including preventive medication practices. Your previous seizures and withdrawal history can still guide assessment while those management uncertainties remain.[1]

Why Does Repeatedly Quitting and Restarting Benzodiazepines Matter?

Each interruption can expose a physically dependent person to withdrawal again, and abrupt stopping or rapid reduction can cause serious complications. Repeated withdrawal also raises concern about seizure-related sensitization. A more difficult episode alone cannot establish that kindling caused it.[1][3][2]

For example, a prescription gap followed by severe insomnia needs review of the medication interruption, the original sleep problem and other medicines or substances. Tell your prescriber what happened and address access problems before another interruption. Do not stop, restart or change your dose on your own. Previous difficulty does not mean future treatment is hopeless.[1][3]

How Is Benzodiazepine Kindling Related to Alcohol Kindling?

Both involve concern that repeated withdrawal may produce a more sensitive response. Alcohol kindling research includes clinical associations and animal findings, as described in Becker’s 1998 review. It helps explain the concept but cannot establish identical mechanisms, risks or outcomes for benzodiazepine withdrawal.[4]

For example, an alcohol-withdrawal seizure-risk estimate cannot predict your risk during a benzodiazepine taper. Treatment evidence from alcohol withdrawal also cannot guarantee seizure prevention during benzodiazepine withdrawal. Tell your clinician about alcohol use and previous alcohol withdrawal, and do not use alcohol to manage benzodiazepine withdrawal symptoms.[1][3][4]

Does the Kindling Effect Increase Seizure Risk?

Repeated withdrawal raises concern about increased seizure susceptibility or severity, but these sources cannot quantify an individual’s added risk. A mouse study supports a seizure-sensitivity signal, and the current clinical guideline takes previous withdrawal seizures seriously. How anxious you feel is not a test of your seizure risk.[1][2]

A gradual, individualized medical plan can lower withdrawal risk without eliminating it. Tell your prescriber about any previous seizure before changing treatment. In the U.S., call 911 for a seizure, trouble breathing or another medical emergency, regardless of whether kindling has been considered.[1][3]

How Do I Avoid Kindling When Coming Off Benzodiazepines?

No approach is proven to eliminate kindling risk. The practical priority is to avoid abrupt, self-directed medication changes and develop an individualized plan with your prescriber. Review the benefits and risks of continuing or reducing treatment, previous withdrawal experiences, other medicines and substances, and whether you need more intensive care. Not everyone taking a benzodiazepine needs to stop.[1][3]

If reduction is appropriate, a gradual supervised taper can lower withdrawal risk. Agree on follow-up, whom to contact if symptoms become difficult, and treatment for anxiety or sleep problems. For example, ask what the plan will be if insomnia again interferes with work. A difficult earlier attempt is useful information for planning future care.[1]

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

5 Sources
  1. American Society of Addiction Medicine. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when benzodiazepine risks outweigh benefits. https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/benzodiazepine-tapering-2025/bzd-tapering-document---final-approved-version-for-distribution-02-28-25.pdf Read source 1
  2. Ward, B. O., & Stephens, D. N. (1998). Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity. Psychopharmacology, 135(4), 342–352. https://doi.org/10.1007/s002130050521 Read source 2
  3. U.S. Food and Drug Administration. (2020, September 23). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class Read source 3
  4. Becker, H. C. (1998). Kindling in alcohol withdrawal. Alcohol Health & Research World, 22(1), 25–33. https://pmc.ncbi.nlm.nih.gov/articles/PMC6761822/ Read source 4
  5. 988 Suicide & Crisis Lifeline. (n.d.). 988 Suicide & Crisis Lifeline. https://988lifeline.org?oai_link_source=model_response_hotline Read source 5
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.